Skip to content
Screener

Alamar Biosciences ALMR Q1 2026 earnings

Reported May 8, 2026 · Before market open

Revenue$26.0MBeat by $26.3K
EPS-$1.74Miss by $0.03
Revenue estimate$26.0M
EPS estimate-$1.71

Next report

Aug 10, 2026 (In 3 days)
Revenue estimate$25.9M
EPS estimate-$0.31

Financials

Q1 2026

Income statement

See full
Revenue$26.0M+98.9%
Gross profit$14.5M+126%
Operating income-$12.3M-44.4%
Net income-$21.3M-178%
EPS (diluted)-$1.74-156%

Balance sheet

See full
Cash & equivalents$64.6M—
Total debt$30.6M—
Total equity-$178.1M—
Total assets$186.5M—

Cash flow

See full
Operating cash flow-$20.3M-55.7%
CapEx$600.0K+8.3%
Free cash flow-$20.9M-53.8%

Valuation & ratios

Valuation

as of 08/06/26
See full
Market cap$1.96B+37.6%
Enterprise value$1.93B—

Returns & leverage

See full
Current ratio5.9×—

Segments

By geography

See full
EMEA$4.0M+179%
Asia Pacific$2.4M+435%
Americas$1.3M+6,335%

By product

See full
Consumables$14.0M+178%
Instruments$7.4M+78.0%
Service$4.7M+27.8%

Versus estimates

Revenue

Q1 2026$26.0MBeat by $26.3K

Diluted EPS

Q1 2026-$1.74Miss by $0.03

FAQ

When did Alamar Biosciences report Q1 2026 earnings?
Alamar Biosciences (ALMR) reported Q1 2026 earnings on May 8, 2026 before market open.
What were Alamar Biosciences's Q1 2026 revenue and EPS?
Alamar Biosciences reported revenue of $26.0M and eps of $-1.74 for Q1 2026.
Did Alamar Biosciences beat estimates in Q1 2026?
Revenue beat the consensus estimate of $26.0M by $26.3K. EPS missed the consensus estimate of $-1.71 by $0.03.
Where can I find Alamar Biosciences's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-213379) and the 10-Q periodic report (0001193125-26-213424) directly on SEC EDGAR. The filing index links above go to sec.gov.